As a matter of fact, CD44 has been shown to be overexpressed in various types of cancers, and a subfamily of CD44 splice variants encompassing the variant domain 6 (CD44v6) has been implicated in the metastatic potential of tumours [28,29]. This evidence concerns the gene CD44 and cancer.